Related Experiment Video
Updated: Jan 29, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Living-Donor Kidney Transplant-Associated Thrombotic Microangiopathy Successfully Treated With Thymoglobulin: A Case
Ahmed Akl1, Sami Alobaidi, Ghaleb Aboalsamh
1From the Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia; and the Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Abstract:
Transplantation is the ultimate therapy for end-stage kidney disease. Early graft dysfunction is a devastating event to patients and carries risk of graft loss. Medical causes of early graft loss include graft rejection, drug toxicity, and thrombotic microangiopathy. Here, we report a case of posttransplant thrombotic microangiopathy associated with cellular vascular rejection. Thymoglobulin successfully reversed vascular rejection and thrombotic microangiopathy associated with half dosing of calcineurin inhibitors.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Structure
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:

